CONSIDERATIONS TO KNOW ABOUT API PHARMACEUTICAL

“The present situation has uncovered some structural weaknesses in the EU’s medicines supply chain and also a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides said. She proposed that provide chain problems be tackled within an EU pharmaceutical system expected to be introduced by the end on